Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study-Reference-Cited by-同舟云学术

Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study

Published:2013-10-28 Issue:2 Volume:30 Page:163-175
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Stenlöf Kaj¹,Cefalu William T.²³,Kim Kyoung-Ah⁴,Jodar Esteban⁵,Alba Maria⁶,Edwards Robert⁶,Tong Cindy⁶,Canovatchel William⁶,Meininger Gary⁶

Affiliation:

1. Clinical Trial Center, Sahlgrenska University Hospital GothenburgSweden

2. Pennington Biomedical Research Center Baton Rouge, LAUSA

3. LSUHSC School of Medicine New Orleans, LAUSA

4. Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University School of Medicine GoyangKorea

5. Department of Endocrinology, Hospital Quiron MadridSpain

6. Janssen Research & Development, LLC Raritan, NJUSA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2013.850066

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of sodium–glucose cotransporter 2 inhibitors on serum low‐density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus;Journal of Diabetes Investigation;2024-03-08

2. Comparative safety of different recommended doses of sodium–glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials;Frontiers in Endocrinology;2023-11-10

3. Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus;Advanced Therapeutics;2023-09-28

4. Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Pneumonia and Septic Shock;The Journal of Clinical Endocrinology & Metabolism;2022-10-01

5. Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis;BMJ Medicine;2022-09